Bridge Point Capital
Overview
Bridge Point Capital is a private equity firm with a focus on U.S-Asia cross-border investments in mid- to late-stage healthcare, technology, and other high-growth companies.
Portfolio Companies
2
Website
bridgepoint.capitalInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Clerio Vision | Mar 2023 | Series E Extension | Co-investor |
| Curio Digital Therapeutics | Aug 2024 | Series A | Co-investor |
Key People
Nadia Tian
Co-Founder
Eric Francom
Partner and Senior Business Development Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bridge Point Capital based?
Bridge Point Capital is headquartered in New York City, New York, United States.
When was Bridge Point Capital founded?
Founding year information for Bridge Point Capital is not publicly available.
How many portfolio companies does Bridge Point Capital have?
Bridge Point Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Bridge Point Capital's portfolio?
Portfolio companies visible on Caplight include Clerio Vision, Curio Digital Therapeutics.
What was Bridge Point Capital's most recent investment shown here?
Bridge Point Capital's most recent investment in this portfolio sample was in Curio Digital Therapeutics in 2024.
What sectors does Bridge Point Capital focus on?
Bridge Point Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Bridge Point Capital focus on?
Stage focus information for Bridge Point Capital is not publicly available.